Plain-English translation of NCT05930899 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building a large collection of biological samples—blood, saliva, and heart tissue—from people with various heart conditions, including aortic valve disease. By studying the genes and proteins in these samples, the research team hopes to discover new biomarkers (measurable signs in your body) that can help doctors better diagnose and treat heart diseases in the future.
Heart disease risk varies greatly from person to person, and much of that difference comes from our genes. Currently, doctors don't have enough genetic information to fully understand who is at highest risk or how to personalize treatment. This study aims to close that gap by creating a resource that researchers can use for years to come.
You likely qualify if…
You likely don't qualify if…
If you join, you will be asked to provide blood samples, a saliva sample, and possibly heart tissue that is removed during planned heart surgery. The research team will store these samples securely in a biobank (a tissue library) and use them to study genes and proteins related to heart disease. There is no long-term follow-up or repeated visits required beyond your surgical care—your main participation is the sample donation itself.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
Canada